China approves AstraZeneca’s lung cancer treatment
China has approved AstraZeneca’s drug Imfinzi to treat aggressive types of lung cancer in adults, to boost its efforts to tackle the disease.
According to a British pharmaceutical company, the drug’s combination with chemotherapy is for…